L264-0407 Screening compound: N-[5-(2-acetamido-5-methylbenzenesulfonamido)-1,3-benzothiazol-2-yl]benzamide

L264-0407 Screening compound: N-[5-(2-acetamido-5-methylbenzenesulfonamido)-1,3-benzothiazol-2-yl]benzamide
L264-0407 Screening compound: N-[5-(2-acetamido-5-methylbenzenesulfonamido)-1,3-benzothiazol-2-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L264-0407
N-[5-(2-acetamido-5-methylbenzenesulfonamido)-1,3-benzothiazol-2-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L264-0407

Molecular Formula

C23H20N4O4S2 (C23 H20 N4 O4 S2)

Compound Name

N-[5-(2-acetamido-5-methylbenzenesulfonamido)-1,3-benzothiazol-2-yl]benzamide

IUPAC name

N-[5-(2-acetamido-5-methylbenzenesulfonamido)-13-benzothiazol-2-yl]benzamide

SMILES

CC(Nc(ccc(C)c1)c1S(Nc(cc1)cc2c1sc(NC(c1ccccc1)=O)n2)(=O)=O)=O

InChI

InChI=1S/C23H20N4O4S2/c1-14-8-10-18(24-15(2)28)21(12-14)33(30,31)27-17-9-11-20-19(13-17)25-23(32-20)26-22(29)16-6-4-3-5-7-16/h3-13,27H,1-2H3,(H,24,28)(H,25,26,29)

InChI Key

AZZJLYSLOZNBCZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15121491

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

480.57

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.722

Distribution Coefficient, logD

2.081

Water Solubility, LogSw

-3.94

Polar Surface Area

96.305

Acid Dissociation Constant (pKa)

5.77

Base Dissociation Constant (pKb)

-1.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

8.70

L264-0407 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with L264-0407 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L264-0407?
Check Price and Availability of L264-0407, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L264-0407 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L264-0407
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L264-0407
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L264-0407 available by request